4//SEC Filing
Kraus Al 4
Accession 0001104659-21-112499
CIK 0001175151other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:31 PM ET
Size
9.5 KB
Accession
0001104659-21-112499
Insider Transaction Report
Form 4
Kraus Al
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-08-31−4,000→ 0 totalExercise: $4.13From: 2012-01-18Exp: 2022-01-18→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2021-08-31$4.13/sh+4,000$16,500→ 129,046 total - Sale
Common Stock
2021-08-31$9.40/sh−4,000$37,591→ 125,046 total
Footnotes (2)
- [F1]Reflects the weighted average price of sales on August 31, 2021. The shares were sold in multiple transactions at prices ranging from $9.38 to $9.409, inclusive. The reporting person undertakes to provide to CytoSorbents Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of the Company as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 55,746 shares of common stock owned by the reporting person.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001368152
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:31 PM ET
- Size
- 9.5 KB